NO20052505L - Ny bruk av dextran-sulfat - Google Patents

Ny bruk av dextran-sulfat

Info

Publication number
NO20052505L
NO20052505L NO20052505A NO20052505A NO20052505L NO 20052505 L NO20052505 L NO 20052505L NO 20052505 A NO20052505 A NO 20052505A NO 20052505 A NO20052505 A NO 20052505A NO 20052505 L NO20052505 L NO 20052505L
Authority
NO
Norway
Prior art keywords
dextran sulfate
new use
human patient
cell transplant
therapeutic
Prior art date
Application number
NO20052505A
Other languages
English (en)
Other versions
NO326946B1 (no
Inventor
Olle Korsgren
Bo Nilsson
Original Assignee
Prophy Med Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prophy Med Ab filed Critical Prophy Med Ab
Publication of NO20052505L publication Critical patent/NO20052505L/no
Publication of NO326946B1 publication Critical patent/NO326946B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/64—Animal cells
NO20052505A 2002-11-28 2005-05-25 Anvendelse av dekstransulfat for behandling av IBMIR NO326946B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0203526A SE525461C3 (sv) 2002-11-28 2002-11-28 Ny användning av dextransulfat
PCT/SE2003/001830 WO2004047848A1 (en) 2002-11-28 2003-11-26 New use of dextran sulfate

Publications (2)

Publication Number Publication Date
NO20052505L true NO20052505L (no) 2005-06-20
NO326946B1 NO326946B1 (no) 2009-03-16

Family

ID=20289705

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052505A NO326946B1 (no) 2002-11-28 2005-05-25 Anvendelse av dekstransulfat for behandling av IBMIR

Country Status (26)

Country Link
US (5) US8629123B2 (no)
EP (1) EP1567171B1 (no)
JP (2) JP4315908B2 (no)
KR (1) KR100828807B1 (no)
CN (1) CN1296051C (no)
AT (1) ATE359798T1 (no)
AU (1) AU2003302378B2 (no)
BR (1) BRPI0316666B8 (no)
CA (1) CA2507595C (no)
CY (1) CY1106739T1 (no)
DE (1) DE60313356T2 (no)
DK (1) DK1567171T3 (no)
EA (1) EA010409B1 (no)
ES (1) ES2285270T3 (no)
HK (1) HK1087042A1 (no)
HR (1) HRP20050439B1 (no)
IL (1) IL168626A (no)
IS (1) IS2405B (no)
NO (1) NO326946B1 (no)
NZ (1) NZ540744A (no)
PL (1) PL216067B1 (no)
PT (1) PT1567171E (no)
SE (1) SE525461C3 (no)
SI (1) SI1567171T1 (no)
WO (1) WO2004047848A1 (no)
ZA (1) ZA200504111B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101588808A (zh) * 2006-10-20 2009-11-25 澳大利亚国立大学 对细胞外基质降解的抑制
WO2008153962A2 (en) * 2007-06-08 2008-12-18 The Trustees Of The University Of Pennylvania Method of reducing tissue loss in pancreatic islet cell transplantation
US20130143840A1 (en) * 2010-03-12 2013-06-06 Christopher Richard Parish Heparan sulfate replacement therapy
US9446066B2 (en) * 2010-07-16 2016-09-20 Tx Medic Ab Methods for reducing pulmonary uptake of intravenously injected cells
CN102973592A (zh) * 2012-11-26 2013-03-20 合肥博太医药生物技术发展有限公司 硫酸葡聚糖在制备治疗糖尿病药物中的应用
SE537742C2 (sv) * 2013-05-13 2015-10-13 Tx Medic Ab Dextransulfat för cellmobilisering
GB201408233D0 (en) 2014-05-09 2014-06-25 Austrianova Singapore Pte Ltd Use of polyanionic composition
BR112016029008B1 (pt) * 2014-06-12 2023-05-02 Tx Medic Ab Uso de sulfato de dextrana com peso molecular médio abaixo de 10000 da para induzir a angiogênese em um sujeito
WO2015190989A1 (en) * 2014-06-12 2015-12-17 Tx Medic Ab The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
SE539575C2 (en) * 2015-07-30 2017-10-17 Tx Medic Ab Dextran sulfate for use in treating, inhibiting or preventing cardiac fibrosis
CA3074987A1 (en) * 2017-09-08 2019-03-14 Tx Medic Ab New use of dextran sulfate
SE544768C2 (en) * 2021-03-24 2022-11-08 Tx Medic Ab Combination for treatment of thromboinflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
TW318142B (no) 1991-06-03 1997-10-21 Mitsubishi Chemicals Co Ltd
US5464815A (en) 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
CN1178070A (zh) * 1996-09-27 1998-04-08 刘春江 组织脏器移植用保存溶液·手术等时组织脏器保护溶液
CN1057192C (zh) * 1997-09-10 2000-10-11 上海长征医院 一种配制多器官保存液的方法

Also Published As

Publication number Publication date
HK1087042A1 (en) 2006-10-06
US8906884B2 (en) 2014-12-09
ES2285270T3 (es) 2007-11-16
US20160136331A1 (en) 2016-05-19
IL168626A (en) 2011-06-30
US9364499B2 (en) 2016-06-14
BR0316666A (pt) 2005-10-11
SE0203526L (sv) 2004-05-29
BRPI0316666B8 (pt) 2021-05-25
EA200500757A1 (ru) 2005-12-29
US20140093484A1 (en) 2014-04-03
HRP20050439B1 (en) 2007-11-30
SI1567171T1 (sl) 2007-08-31
IS7908A (is) 2005-06-23
EP1567171B1 (en) 2007-04-18
JP2009167201A (ja) 2009-07-30
US20060111319A1 (en) 2006-05-25
DK1567171T3 (da) 2007-07-16
IS2405B (is) 2008-09-15
HRP20050439A2 (en) 2005-12-31
CN1717240A (zh) 2006-01-04
SE0203526D0 (sv) 2002-11-28
NO326946B1 (no) 2009-03-16
PL216067B1 (pl) 2014-02-28
DE60313356D1 (de) 2007-05-31
JP2006509057A (ja) 2006-03-16
US20140094435A1 (en) 2014-04-03
US8629123B2 (en) 2014-01-14
EA010409B1 (ru) 2008-08-29
BRPI0316666B1 (pt) 2018-09-25
US8901104B2 (en) 2014-12-02
US10307440B2 (en) 2019-06-04
US20100113389A1 (en) 2010-05-06
WO2004047848A1 (en) 2004-06-10
NZ540744A (en) 2007-02-23
ZA200504111B (en) 2006-07-26
PL376302A1 (en) 2005-12-27
EP1567171A1 (en) 2005-08-31
AU2003302378A1 (en) 2004-06-18
CN1296051C (zh) 2007-01-24
CA2507595A1 (en) 2004-06-10
CA2507595C (en) 2011-11-08
CY1106739T1 (el) 2012-05-23
JP4972113B2 (ja) 2012-07-11
SE525461C3 (sv) 2005-03-23
JP4315908B2 (ja) 2009-08-19
SE525461C2 (sv) 2005-02-22
PT1567171E (pt) 2007-07-09
KR20050089803A (ko) 2005-09-08
ATE359798T1 (de) 2007-05-15
AU2003302378B2 (en) 2008-02-21
KR100828807B1 (ko) 2008-05-09
DE60313356T2 (de) 2007-08-16

Similar Documents

Publication Publication Date Title
NO20052505L (no) Ny bruk av dextran-sulfat
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
NO20065904L (no) Terapeutiske forbindelser
EP2277992A3 (en) Progenitor cells from Wharton's jelly of human umbilical cord
SE9604786D0 (sv) New compounds
BR0111300A (pt) Implante de neurotoxina
YU4602A (sh) Farmaceutske formulacije zaštićene od dejstva mikroorganizama
BR0203650A (pt) Estentor de auto-articulação
NZ544009A (en) Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
AU3850600A (en) Dalda analogs and their use
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
AU2002239830A1 (en) Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
DK0998287T3 (da) Anvendelse af levobupivacain
EP2364708A3 (en) Pharmaceutical composition comprising a ClC-2 channel opener
DK1569679T3 (da) Chaperonin-10-immunosuppression
BR0312365A (pt) Meio de cultura autólogo de células-mães progenitoras autólogas humanas, métodos para a preparação do mesmo e de uma composição de células-mães progenitoras autólogas humanas e para a obtenção de células-mães progenitoras musculares autólogas humanas, emprego de um meio de cultura autólogo de células-mães progenitoras autólogas humanas, procedimento para a obtenção de células-mães progenitoras musculares autólogas humanas e procedimento terapêutico de cardiomioplastia celular autóloga, composição enriquecida com células-mães progenitoras musculares autólogas humanas e composição farmacêutica
EP2072082A3 (en) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3 sulfonamide as analgetic agent
RS51420B (en) HYPERSTRUCTURE AMYLOPECTIN FOR USE IN THE PROCEDURES OF SURGICAL OR THERAPEUTIC TREATMENT OF mammals OR IN THE PROCEDURES OF DIAGNOSIS, AND PARTICULARLY FOR USE AS A PLASMA VOLUME EXPANDER
BRPI0407335A (pt) Agentes antibacterianos
HUP0203486A2 (hu) Véralvadással összefüggő betegségek megelőzése és kezelése
NO20022109D0 (no) Anvendelse av treosulfan for behandling av pasienter för benmargs- eller blodstamcelletansplantasjon
DE60130253D1 (de) Zusammensetzungen zur verhinderung der adhäsion
PT1067907E (pt) Solucao para irrigacao ocular
RU99111148A (ru) Глазные капли

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees